MSD's pulmonary arterial hypertension (PAH) drug Winrevair has been accelerating at a breakneck pace since its launch earlier this year – and data from a new phase 3 study could give it a turbo boost.

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD, known as Merck & Co., Inc., Rahway, NJ, USA, in the United States and Canada, officially launched the Minah Holobox Experience Tour, an interactive community education initiative that leverages ...

Reston, Va., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Noblis MSD, a Noblis subsidiary and leading provider of science, technology and engineering services to the U.S. military, today announced that it has ...

Adam Piekarski decided to go it alone after more than a decade at BDT & MSD Partners. He’s backing up that bet with a historic unveiling. Derby Lane Partners has amassed $1.8 billion in commitments ...

Rising use “is not a signal of satisfaction,” an author of a new report says. Rather, heavy users of the apps are under “financial strain.” By Ann Carrns Pay-advance apps are marketed as a way to help ...

MSD (Merck & Co., Inc.) will vacate its laboratories at the Francis Crick Institute in London by end‑2025 as it winds down discovery research in the UK. The move follows the decision to scrap a ...

Summit founder and president Quint Rubald, CEO Jeff Evrard and the broader management team will remain shareholders and continue to lead the company Founded in 1999, Summit has locations across 37 ...

Pharmaceutical giant MSD is slashing $3bn (€2.59bn) from its annual spending as part of global job cut but said it will not be closing any of its Irish sites. Pharmaceutical giant MSD is slashing $3bn ...

MSD is slashing $3bn (€2.59bn) from its annual spending as it braces for off-brand competition to its Irish-manufactured cancer drug Keytruda, the best-selling medicine in the world. The drugmaker ...